Publications
Print PDF
What the Moderna-NIH COVID Vaccine Patent Fight Means for Research
November 30, 2021
Heidi Ledford
Nature

Axinn partner Chad Landmon was quoted in the Nature article, "What the Moderna-NIH COVID Vaccine Patent Fight Means for Research."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.